But with two strong options available, youre likely wondering: Which one is right for me
Our long-term analysis of semaglutide in a large and diverse cohort of patients with type 2 diabetes found a clinically relevant improvement in blood sugar control and weight loss after 6 months of treatment, comparable with that seen in randomised trials, said investigator Avraham Karasik, MD, lead author and professor at the Institute of Research and Innovation at Maccabi Health Services in Israel, the second largest health maintenance organization in the country
In the low/no CKD risk cohort, one patient suspended treatment at 7 months due to the absence of effect on body weight
Switching for cardiovascular protection If the cardiovascular outcome data from the SELECT trial influenced your switch decision, the target formulation is typically Wegovy at 2.4 mg weekly
Instead of treating every patient the same, the platform begins with a detailed health review completed by licensed healthcare professionals
To stay safe, choose a service with board-certified providers, a US address and phone number, and clear follow-up care, and avoid any site offering semaglutide at prices that seem too good to be true
